COVID 19 vaccine: WHO to launch 2nd Solidarity Trial
Geneva: In a recent announcement, the World Health Organisation (WHO), on April 3, has stated that it is soon going to launch a second protocol for the Solidarity Trial for coronavirus vaccine.
"WHO would soon be launching a second protocol for the Solidarity Trial that will help establish incidence and prevalence of infection and the future behaviour of the virus," Dr Poonam Khetrapal Singh, Regional Director of WHO South-East Asia said in a press statement recently, quotes IANS.
The Regional Director commended countries in the Region for participating in the WHO Solidarity Trial.
At least three South-East Asia member countries, including India, Indonesia and Thailand have already signed up for the multi-country trial, which will compare the safety and effectiveness of four different drugs or drug combinations against COVID-19.
On April 2, the World Health Organisation chief told media at a press conference "The Solidarity trial, which is assessing potential treatments for COVID-19, has already brought in 74 countries, which have either joined the trial or are in the process of joining," adding more than 200 patients have been randomly assigned to one of the study arms.
"It is a historic undertaking that will dramatically reduce the time needed to generate robust evidence about what drugs are effective in treating COVID-19. The more countries that join, the faster we will have the results. I urge all countries to sign up," Dr Khetrapal Singh said.
The Regional Director held a virtual meeting with health ministers of the Region to review the challenges. Most countries highlighted the need for essential medical equipment, testing kits, personal protective equipment for health workers and enhancing health systems capacities, specially to respond to community transmission.
Read Also: Maintaining essential health services during the COVID-19 pandemic: WHO guidelines
